MeSH tree: C17.800
A Global Burden of Disease analysis estimated that the annual number of alcohol-attributable cancer deaths in the U.S. increased from 11,361 in 1990 to 23,126 in 2023. The study also revealed that alcohol-linked cancer deaths ...
Sep 2, 2026
0
253
A genetic marker already used to flag the risk of a life-threatening reaction to the antibiotic vancomycin also identifies patients at risk of that reaction to lamotrigine—and it is missing from the gene panels clinicians ...
Sep 2, 2026
0
5
The U.S. Food and Drug Administration has approved Lisraya (brepocitinib) tablets as the first oral treatment for dermatomyositis in adults.
Sep 1, 2026
0
5
Cancers actively remodel their surrounding cells and tissues to create a microenvironment that favors their growth, survival and spread. Melanoma, a cancer of the pigment-producing melanocytes of the skin, is one of the most ...
Sep 1, 2026
0
10
Triple-negative breast cancer (TNBC) has a frustrating ability to adapt. Although this aggressive form of breast cancer can initially respond well to chemotherapy, cancer cells often find ways to survive, allowing the disease ...
Aug 31, 2026
0
11
Triple-negative breast cancer (TNBC) is the most aggressive type of breast cancer. Chemotherapy before or after surgery remains the standard treatment regimen for stage I–III TNBC. Only a small portion of patients can benefit ...
Aug 31, 2026
0
5
Scroll through social media and you will encounter a strange vocabulary for an old impulse: "tanmaxxing," "UV chasing" and "SPF shunning." In some corners of the internet, sunscreen is described as toxic, while a "natural" ...
Aug 27, 2026
0
7
Two major international Peter Mac-led studies have found AI models were just as good as human pathologists at a task that predicts outcomes for patients with breast cancer.
Aug 26, 2026
0
10
Researchers have created one of the most detailed maps to date of how white blood cells called B cells develop and behave inside melanoma tumors, a type of skin cancer. The study, led by King's College London and published ...
Aug 25, 2026
0
4
Cornell researchers successfully ramped up the body's own immune response to fight melanoma at the tail end of targeted cancer therapy, when tumors commonly become resistant to these therapies and leave behind residual cancer ...
Aug 24, 2026
0
6
